Esketamine Nasal Spray versus Quetiapine for Resistant Depression. Reply
N Engl J Med
.
2024 Jan 4;390(1):94-95.
doi: 10.1056/NEJMc2313230.
Authors
Andreas Reif
1
,
Siobhán Mulhern-Haughey
2
,
Yordan Godinov
3
Affiliations
1
University Hospital Frankfurt-Goethe University, Frankfurt am Main, Germany reif@med.uni-frankfurt.de.
2
Janssen EMEA, Dublin, Ireland.
3
Janssen EMEA, Sofia, Bulgaria.
PMID:
38169504
DOI:
10.1056/NEJMc2313230
No abstract available
Publication types
Letter
Comment
MeSH terms
Antidepressive Agents / therapeutic use
Depression*
Humans
Nasal Sprays*
Quetiapine Fumarate / therapeutic use
Substances
Quetiapine Fumarate
Nasal Sprays
Esketamine
Antidepressive Agents